Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Local Recurrence of Malignant Tumor of ProstateRadiotherapy
Interventions
RADIATION

Stereotactic Body Radiotherapy

"Salvage SBRT will be performed in three subgroups of patients with local recurrence:~Group A - after conventionally fractionated/moderately hypofractionated definitive radiotherapy; Group B - after prostatectomy and postoperative radiotherapy; Group C - after ultrahypofractionated definitive SBRT~Target volumes:~GTV- tumour visible on MRI and PET-CT; CTV- 1-3 mm margin around GTV PTV- 3 mm around CTV\*~\*- in cases in which very high accuracy and reproducibility of SBRT are ensured, and the margin overlaps the rectum and/or bladder, it is possible to reduce the margin from these organs to 1 mm.~Dose constrains:~The criteria for limiting the dose in nearby organs are not well-defined for repeated irradiation - the following doses should be aimed:~* Maximum rectal dose ≤103% of the prescribed dose (optimal ≤100%)~* Maximum bladder dose ≤105% of the prescribed dose (optimal ≤103%)~Dose-volume constrains:~Rectum:~• D30% \<15Gy~Bladder:~• D30% \< 15 Gy"

Trial Locations (1)

44-100

RECRUITING

Maria Sklodowska Memorial Research Institute of Oncology, Gliwice

All Listed Sponsors
lead

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER